M.D., Ph.D., Assistant Professor of Medicine (Oncology), Stanford
The major focus of Dr. Alizadeh’s research group is to attain a better understanding of the initiation, maintenance, and progression of lymphoid tumors, and their response to existing and novel therapies toward improving current treatment strategies. In this effort, they employ tools from functional genomics, computational biology, molecular genetics, and mouse models. They hope to apply this knowledge towards the design of clinical trials in the treatment of patients with lymphoma, leukemia, and myeloma.
Session Abstract – PMWC 2018 Silicon Valley
Session Synopsis: This session will cover applications of NGS-based liquid biopsy testing that are either currently available clinically or that are being actively explored in research studies.